Astrana Health Inc (ASTH)

Gross profit margin

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Gross profit (ttm) US$ in thousands 62,390 352,794 655,222 667,276 659,440 372,258 273,150 279,381 282,705 277,749 259,432 244,682 339,593 325,125 327,093 301,208 203,367 203,429 32,853 84,414
Revenue (ttm) US$ in thousands 1,430,308 1,370,544 1,320,971 1,290,981 1,216,473 1,141,551 1,042,443 956,310 860,054 772,314 753,997 703,282 791,586 779,252 781,220 758,589 625,959 559,479 486,184 498,232
Gross profit margin 4.36% 25.74% 49.60% 51.69% 54.21% 32.61% 26.20% 29.21% 32.87% 35.96% 34.41% 34.79% 42.90% 41.72% 41.87% 39.71% 32.49% 36.36% 6.76% 16.94%

March 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $62,390K ÷ $1,430,308K
= 4.36%

The gross profit margin of Astrana Health Inc has shown significant fluctuation over the past few quarters, ranging from as low as 4.36% to as high as 54.21%. The gross profit margin is a key indicator of a company's profitability and efficiency in managing its production costs.

The trend observed indicates that there have been periods of strong performance, with gross profit margins exceeding 40%, particularly in the latter part of 2020 and early 2021. This suggests that the company was able to generate a substantial profit after accounting for the cost of goods sold during those periods.

However, there are also instances where the gross profit margin dropped significantly, such as in the first quarter of 2020 and the first quarter of 2024, where margins were below 10%. This could be indicative of challenges in maintaining profitability or managing production costs effectively during those specific periods.

Overall, the analysis of Astrana Health Inc's gross profit margin reveals a varying performance over the past few quarters, indicating fluctuations in profitability and cost management practices. Further investigation into the factors influencing these fluctuations would be necessary to gain a deeper understanding of the company's financial health.